Tag: Cleerly

Cleerly to Debut Cleerly PREVIEW and Showcase New AI-QCT Research at ACC.26

DENVER–(BUSINESS WIRE)– #AI–Cleerly, a leader in advanced cardiovascular imaging analysis, will be attending the 75th Annual Scientific Session & Expo of the American College of Cardiology (ACC.26). The conference will take place March 28–30, 2026, at the Ernest N. Morial Convention Center in New Orleans, Louisiana. ACC.26 convenes clinicians, researchers, and innovators from around the world to advance the science and practice of heart care. Cleerly will mark the conference with the launch of

Cleerly AI-QCT Demonstrates High Agreement with Invasive IVUS in INVICTUS Registry

DENVER–(BUSINESS WIRE)– #AI–Cleerly, a leader in AI-based cardiovascular imaging analysis, presented findings from its multicenter INVICTUS registry at the recent European Congress of Radiology (ECR 2026) in Vienna, Austria. The presentation titled, “Artificial Intelligence-Based CCTA Quantification of Atherosclerosis Burden: Comparison With IVUS in the INVICTUS Registry” was presented by Rine Nakanishi, MD, PhD, during the Clinical Trials in Radiology: Spotlight Session on March 5, 2026. The anal

CVCT 2025: Cleerly Late-Breaking Science Identifies Thresholds of High Plaque Burden in Non-Obstructive CAD that May Carry Greater Risk Than Obstructive Disease

DENVER–(BUSINESS WIRE)–Cleerly, a leader in AI-based cardiovascular imaging, presented new, late-breaking science from the international CONFIRM2 Registry at the Global CVCT Scientific Program 2025 in Washington, DC. “These findings fundamentally change how we should assess cardiac risk in patients by addressing the historically overlooked risk of non-obstructive coronary artery disease,” said Andrew […]

Cleerly Unveils PowerScribe Integration and Lesion-Level Reporting at RSNA 2025

DENVER–(BUSINESS WIRE)–Cleerly, a leader in AI-based cardiovascular imaging, will showcase new product updates at RSNA 2025, November 30 – December 4, 2025, at McCormick Place in Chicago, IL. At Booth #8039, Cleerly will demonstrate PowerScribe integration and newly added lesion-level reporting, discuss new clinical research findings, and provide guidance on the […]

AHA 2025 Late-Breaking Science: Cleerly’s AI Atherosclerosis Quantification Outperforms Traditional Risk Scoring

DENVER–(BUSINESS WIRE)–Cleerly, a leader in AI-based cardiovascular imaging, presented new, late-breaking science from the international CONFIRM2 Registry at the American Heart Association (AHA) Scientific Sessions 2025 at the Ernest N. Morial Convention Center in New Orleans, LA. “This is another step towards earlier identification and treatment for patients,” said Ibrahim Danad, MD, […]

TCT 2025 Late-Breaking Science: Quantitative Assessment of Non-Calcified Plaque Volume Drives Risk for Myocardial Infarction and Death

CONFIRM2 Registry Demonstrates Prognostic Value of AI-Based Plaque Characterization Beyond Stenosis Severity   October 27, 2025 (DENVER, CO) – Cleerly, a leader in AI-based cardiovascular imaging, presented new, late-breaking science from the international CONFIRM2 Registry at the Transcatheter Cardiovascular Therapeutics (TCT) 2025 Conference at the Moscone Center in San Francisco, […]

UnitedHealthcare and Cigna Coverage for Cleerly LABS Advanced Plaque Analysis Begins October 1st

DENVER–(BUSINESS WIRE)–Cleerly, the leader in AI-based advanced cardiovascular imaging, today announced that groundbreaking coverage policies from UnitedHealthcare and Cigna for Cleerly® LABS™ advanced plaque analysis will go into effect on October 1st, 2025. These landmark decisions mark a new era in cardiac care, bringing AI-guided quantitative coronary CT angiography (AI-QCT)/Coronary […]

Cigna Approves Coverage for Cleerly’s AI Cardiovascular Imaging Technology

DENVER–(BUSINESS WIRE)–Cleerly, a leader in AI-based cardiovascular imaging, today announced that Cigna will begin covering Cleerly LABS Advanced Plaque Analysis effective October 1, 2025. The coverage decision makes Cigna the latest major insurer to recognize the clinical and economic value of Artificial Intelligence Enabled CT Based Quantitative Coronary Tomography (AI-QCT)/Coronary […]

Cleerly Demonstrates Significant Cardiovascular Risk Prediction in Late-Breaking Clinical Science at European Society of Cardiology Congress 2025

DENVER–(BUSINESS WIRE)–Cleerly, a leader in AI-based cardiovascular imaging, presented a late-breaking analysis of registry data, Prognostic Value of AI-based Quantitative Coronary CT Evaluation Versus Standard Qualitative Evaluation, and five additional research abstracts at the European Society of Cardiology (ESC) Congress 2025, August 29 – September 1 at the Institución Ferial de […]

Cleerly Unveils Groundbreaking Late-Breaking Clinical Trial Results Demonstrating AI-QCT’s Predictive Power for Women’s Cardiovascular Risk at ACC.25

New Findings from the CONFIRM2 Registry Reveal Significant Gender Disparities in Coronary Plaque Features and Associated Risks for Major Adverse Cardiovascular Events   March 31, 2025 (DENVER) – Cleerly, the leader in cardiovascular AI imaging, has announced revolutionary findings from its late-breaking clinical trial presented at the American College of […]